S. Hossack

The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol

David E. Pierce, Patrick Martin, L. Poole, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects

Nathan Gale, C. Proctor, I. Fearon, 2018, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

A randomised, controlled, two-Centre open-label study in healthy Japanese subjects to evaluate the effect on biomarkers of exposure of switching from a conventional cigarette to a tobacco heating product

Nathan Gale, C. Proctor, I. Fearon, 2017, BMC Public Health.

A solid-state approach to enable early development compounds: selection and animal bioavailability studies of an itraconazole amorphous solid dispersion.

S. Byrn, A. Templeton, A. Newman, 2010, Journal of pharmaceutical sciences.

Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis

Patrick Martin, C. Cuffari, B. Korczowski, 2016, Drug design, development and therapy.

SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting

R. Plummer, Karen So, F. Blackhall, 2017, British Journal of Cancer.

Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NEO6860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist.

A. Griffin, William Brown, Richard L Leff, 2017, The journal of pain : official journal of the American Pain Society.

A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adults

David E. Pierce, M. Corcoran, Patrick Martin, 2015, Drug design, development and therapy.

CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone‐to‐renin ratio, an indicator of sodium retention, in healthy volunteers

P. Mulatero, M. Groessl, H. Brunner, 2023, British journal of clinical pharmacology.

Assessment of pharmacodynamic equivalence and tolerability of lanthanum carbonate oral powder and tablet formulations: a single-center, randomized, open-label, 2-period crossover study in healthy subjects.

Patrick Martin, D. Pierce, Pinggao Zhang, 2012, Clinical therapeutics.